Global Generic Drugs Market Research Report 2022-2027
© 2022 IMARC All Rights Reserved
Author: Elena Anderson Marketing Manager Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group
About IMARC Group
Report Description
International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights Report Description Global Generic Drugs Market Outlook 2022-2027: The latest report by IMARC Group, titled “Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027,” finds that the global generic drugs market size reached US$ 320 Billion in 2021. A generic drug is medicine containing the same active pharmaceutical ingredient (API) and has an equivalent therapeutic effect as the branded drug. It is also identical to branded drugs in terms of quality, safety strength, dosage, route of administration, intended use, effect, form, quality, and side effects. However, it differs in certain characteristics such as color, shape, and flavoring. Compared to patented drugs, generic drugs are cost-effective as manufacturers do not have to invest in clinical trials and research and development (R&D) activities to prove the effectiveness of the medicine. As a result, these drugs are gaining traction among individuals across the globe. Request for a PDF sample of this report: https://www.imarcgroup.com/generic-drug-manufacturing-plant/requestsample
Report Description and Highlights
Report Description
Global Generic Drugs Market Drivers/Constraints: In recent years, governments of developed countries have introduced various initiatives to reduce healthcare costs by promoting the production of generic medicines. Besides this, hospitals, institutions, and various organizations are addressing the shortage of generic drugs across the globe. For instance, a coalition of seven hospitals and three philanthropies in the US declared that they would launch a generic drug company named Civica Rx to meet the drug shortage. Moreover, the governing authorities of numerous countries have introduced several programs to offer incentives to physicians and pharmacists for promoting generic substitution. This, coupled with the growing prevalence of chronic diseases such as diabetes, dyslipidemia, hypertension, and metabolic syndrome, on account of sedentary lifestyles, hectic work schedules, and changing dietary patterns, are creating a positive market outlook across the globe. Furthermore, various branded drugs are set to lose their patent protection in the coming years, which will continue to propel the market growth. View Report TOC, Figures and Tables: https://www.imarcgroup.com/generic-drug-manufacturing-plant
Report Description and Highlights
Report Description Key Market Segmentation
The research report includes the following segments:
Breakup by Therapy Area: • • • • • • • •
Central Nervous System Cardiovascular Dermatology Genitourinary/Hormonal Respiratory Rheumatology Diabetes Oncology
Breakup by Distribution Channel: • •
Retail Pharmacies Hospital Pharmacies
Report Description and Highlights
Report Description Breakup by Drug Delivery: • • • •
Oral Injectables Dermal/Topical Inhalers
Breakup by Region: • • • • •
North America Asia Pacific Europe Latin America Middle East and Africa
Report Description and Highlights
Report Description Competitive Landscape: • • • • • • • • • • •
ABB Ltd Alstom SA Belden Inc Bombardier Inc CAF Construcciones y Auxiliar de Ferrocarriles S.A General Electric Company Hitachi Ltd Kawasaki Heavy Industries Ltd Mitsubishi Heavy Industries Ltd Siemens AG Thales Group
Note: We are updating our reports, If you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and Competitive landscape, etc. Click here: https://www.imarcgroup.com/generic-drug-manufacturing-plant/requestsample
Key Questions Answered in the Report
Report Description
1. What has been the historical growth rate of the global Generic Drugs Market? 2. What has been the impact of COVID-19 on the global Generic Drugs Market? 3. What are the key factors driving the global Generic Drugs Market? 4. What is the breakup of the global Generic Drugs Market based on the type? 5. What is the breakup of the global Generic Drugs Market based on the application? 6. What is the breakup of the global Generic Drugs Market based on the distribution channel? 7. What are the key regions in the global Generic Drugs Market? 8. Who are the key players/companies in the global Generic Drugs Market?
Report Description 1
Preface
2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology
3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends
Table of Contents
Report Description 5
Table of Contents
Global Generic Drugs Market Industry 5.1 5.2 5.3 5.4 5.5 5.6 5.7
Market Overview Market Performance Impact of COVID-19 Market Breakup by Therapy Area Market Breakup by Drug Delivery Market Breakup by Distribution Channel Market Breakup by Region
Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/generic-drug-manufacturing-plant/toc
A partial List of
We are the trusted business partners to the
Clients world's leading corporates, governments, and ourPartial ClientsList of institutions
A partial List of
We are the trusted business partners to the
of Clients leading corporates, governments, and ourPartial ClientsListworld's institutions
Report Description and Highlights
Report Description
© 2022 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Contact Us
FOR MORE DETAILS Visit us at :
https://www.imarcgroup.com Stay With Us:
TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com